Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Cvs Health Corp (CVS) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Top 35% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $111.97B large-cap
Summary

Cvs Health Corp (CVS) stock forecast summary

Our AI ranks Cvs Health Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Cvs Health Corp is a large-cap company with a market capitalization of $111.97B.

A per-ticker accuracy statistic for CVS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CVS included.

Follow CVS free
Price

CVS price chart and AI forecast

CVS
Cross-section · 2026-10-13

How CVS ranks among 5379 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Cvs Health Corp (CVS) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Drug Stores and Proprietary Stores peers listed below that report each metric.

Valuation & Market

MetricCVSIndustry medianRank
Market Cap $111.97B – –
P/E Ratio 22.90x – –
P/B Ratio 1.40x – –
Dividend Yield 3.05% – –
EPS $3.79 – –
Book Value/Share $62.32 – –
Revenue/Share $324.55 – –
FCF/Share $9.19 – –

Profitability & Margins

MetricCVSIndustry medianRank
ROE 6.1% – –
ROA 1.9% – –
ROIC 5.0% – –
Gross Margin 44.5% – –
Operating Margin 2.0% – –
Net Margin 1.2% – –
EBT Margin 1.4% – –
Tax Rate 15.6% – –

Financial Health

MetricCVSIndustry medianRank
Current Ratio 0.87x – –
Quick Ratio 0.66x – –
D/E Ratio 2.18x – –
Financial Leverage 3.18x – –
Interest Coverage 3.0x – –
Working Capital -$11.70B – –

Cash Flow

MetricCVSIndustry medianRank
Operating Cash Flow $14.78B – –
Free Cash Flow $11.76B – –
Capital Spending -$3.02B – –
OCF Growth YoY 95.3% – –
FCF Growth YoY 146.0% – –
FCF/Sales 2.8% – –
CapEx/Sales 0.7% – –

Operational Efficiency

MetricCVSIndustry medianRank
Asset Turnover 1.64x – –
Receivables Turnover 10.3x – –
Inventory Turnover 13.1x – –
Fixed Assets Turnover 31.5x – –
Days Sales Outstanding 35 days – –
Days Inventory 28 days – –

Income Statement

MetricCVSIndustry medianRank
Total Revenue $415.09B – –
Operating Income $8.29B – –
Net Income $4.89B – –
Cost of Goods Sold $230.41B – –

Dividend & Shareholder Information

MetricCVSIndustry medianRank
Dividends Per Share $2.67 – –
Payout Ratio 70.5% – –
Shares Outstanding 1279M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$75.35B29.7% of assets
Cash & Short-term Investments$11.33B4.5% of assets
Accounts Receivable$40.31B15.9% of assets
Inventory$17.62B6.9% of assets
Total Liabilities$173.87B68.5% of assets
Quarterly Financial Reports

CVS quarterly financials and insider trading

Industry Peers · Retail-Drug Stores and Proprietary Stores

Cvs Health Corp (CVS) industry peers

Companies classified under the same SEC industry code as Cvs Health Corp (Retail-Drug Stores and Proprietary Stores): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
CVS Cvs Health Corp ▲ $111.97B 22.9x 1.4x
PETS Petmed Express Inc ▶ $27M – 1.2x
CANN Trees Corp (Colorado) ▲ N/A – –
GRDN Guardian Pharmacy Services, Inc. ▶ N/A – –
RDGT Ridgetech Inc. ▶ N/A – –

Where CVS sits on the market map

Trade & Services · Retail-Drug Stores and Proprietary Stores
Explore the map →
News

Cvs Health Corp (CVS) stock news

Loading...

FAQ

Cvs Health Corp (CVS) stock forecast FAQ

What is the Cvs Health Corp (CVS) stock forecast?

Our AI ranks Cvs Health Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Cvs Health Corp stock predictions?

A per-ticker accuracy statistic for CVS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Cvs Health Corp forecasts updated?

Cvs Health Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Cvs Health Corp's industry peers?

5 issuers in our coverage, CVS included, share the SEC industry code Retail-Drug Stores and Proprietary Stores. The largest are: Petmed Express Inc (PETS), Trees Corp (Colorado) (CANN), Guardian Pharmacy Services, Inc. (GRDN), Ridgetech Inc. (RDGT).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.